Dual antiplatelet therapy is defined as the use of aspirin and P2Y12 receptor inhibitor to prevent blood clotting, and through a double mechanism, it prevents thrombotic complications. The dual antiplatelet therapy is often prescribed for patients who had a cardiac attack, had coronary artery bypass graft surgery (CABG), or were treated with stents in coronary arteries. Growing prevalence of cardiovascular disease on the coattails of changing lifestyles habits is expected to be a key factor influencing the development of dual antiplatelet therapy market. Government initiatives in healthcare infrastructures, especially in emerging economies have favored the adoption of advanced methods of treatment which in turn is likely to create potential growth prospects of dual antiplatelet therapy market in these regions.

For detailed insights on enhancing your product footprint, request for a sample here-  https://www.factmr.com/connectus/sample?flag=S&rep_id=1002

Dual Antiplatelet Therapy Market: Drivers and Restraints

The growing prevalence and recurrence of cardiac diseases is expected to be the major factor driving the growth of the dual antiplatelet therapy market over the forecast period. According to World Health Organization, cardiac disease is the number one cause of death globally. An estimated 17.2 million people die of cardiac diseases, representing 31% of global deaths, annually. Off the 17.2 million people, approximately 7.4 million people died due to coronary heart disease, whereas nearly 6.7 million died due to stroke.

Changes in lifestyle and eating habits are attributed to the growing prevalence of cardiac diseases. Research & Development of antiplatelet therapies is another factor contributing to the growth of the global dual antiplatelet therapy market. However, costs associated and lack of awareness about dual antiplatelet therapy market are some of the factors restraining the growth of dual antiplatelet therapy market.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=T&rep_id=1002

Dual Antiplatelet Therapy Market: Segmentation

Tentatively, the global dual antiplatelet therapy market can be segmented on the basis of product type, indication, distribution channel, and geography.

Based on product type, the global dual antiplatelet therapy market is segmented as:

  • Aspirin
  • Clopidogel
  • Prasugrel
  • Ticagrelor

Based on indications, the global dual antiplatelet therapy market is segmented as:

  • Myocardial Infarction
  • Stable Ischemic Heart Disease
    • Bare-metal stent (BMS)
    • Drug-Eluting Stent (DES)
    • Coronary Artery Bypass Graft Surgery (CABG)
  • Acute Coronary Syndromes
    • Fibrinolysis
    • Percutaneous Coronary Artery Intervention

Based on distribution channel, the global Dual Antiplatelet Therapy Market is segmented as:

  • Hospital Pharmacies
  • Independent Pharmacies
  • Retail Pharmacies
  • Online Pharmacy

For comprehensive insights on this market adoption, ask an analyst here – https://www.factmr.com/checkout/1002/S

Based on geography, the global Antiplatelet Therapy Market is segment as:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan
  • Japan
  • Middle-East & Africa

Dual Antiplatelet Therapy Market: Key Players

The global market for dual antiplatelet therapy is highly fragmented. Examples of some of the key players operating in the global dual antiplatelet therapy market are Bayer AG, Novacap, Shiono Chemical Co., Ltd., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Dr. Reddy’s Laboratories, Eli Lilly & Co. Ltd. and others.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Leave a comment

Your email address will not be published. Required fields are marked *